Header Logo

elliot Servais

Concepts (236)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Robotic Surgical Procedures
11
2024
97
6.450
Why?
Lung Neoplasms
17
2024
555
5.110
Why?
Thoracic Surgery
6
2024
66
3.310
Why?
Esophageal Neoplasms
5
2024
77
2.760
Why?
Thoracic Surgical Procedures
5
2024
32
2.640
Why?
Surgeons
4
2023
155
2.210
Why?
Thoracic Surgery, Video-Assisted
6
2024
51
2.010
Why?
Pneumonectomy
6
2024
81
1.670
Why?
Esophagectomy
4
2024
44
1.510
Why?
Carcinoma, Non-Small-Cell Lung
5
2024
139
1.330
Why?
Early Detection of Cancer
2
2023
265
1.300
Why?
Databases, Factual
8
2024
841
1.170
Why?
Thoracic Wall
2
2023
16
1.030
Why?
Pleural Neoplasms
4
2014
17
0.990
Why?
Mesothelioma
4
2014
26
0.980
Why?
Anastomotic Leak
2
2023
33
0.950
Why?
Suture Techniques
1
2024
84
0.910
Why?
Esophageal Achalasia
1
2023
29
0.830
Why?
Natural Orifice Endoscopic Surgery
1
2023
34
0.830
Why?
Tracheoesophageal Fistula
1
2022
4
0.800
Why?
Humans
47
2024
59512
0.800
Why?
Herpes Simplex
1
2022
46
0.770
Why?
GPI-Linked Proteins
5
2014
35
0.750
Why?
Molecular Imaging
2
2011
47
0.720
Why?
Clinical Competence
2
2024
683
0.700
Why?
Unnecessary Procedures
1
2020
42
0.700
Why?
Radiation Dosage
1
2020
126
0.660
Why?
Tomography, X-Ray Computed
5
2020
1463
0.630
Why?
Retrospective Studies
15
2024
6013
0.620
Why?
Biomedical Research
1
2021
250
0.610
Why?
Societies, Medical
4
2024
330
0.570
Why?
Metastasectomy
1
2016
4
0.520
Why?
Treatment Outcome
9
2024
5180
0.510
Why?
Stomach
2
2012
84
0.470
Why?
Dyspnea
2
2012
108
0.470
Why?
Biomarkers, Tumor
3
2013
454
0.470
Why?
Disease Models, Animal
2
2012
2073
0.460
Why?
Disease Management
1
2016
220
0.450
Why?
Anastomosis, Surgical
2
2024
97
0.440
Why?
Neoplasm Staging
7
2024
455
0.440
Why?
Postoperative Complications
3
2021
1136
0.430
Why?
Tumor Burden
2
2021
62
0.420
Why?
Lymph Nodes
2
2011
212
0.420
Why?
Minimally Invasive Surgical Procedures
2
2024
85
0.420
Why?
Diaphragmatic Eventration
1
2012
2
0.410
Why?
Hernia, Diaphragmatic
1
2012
3
0.410
Why?
Gastric Fistula
1
2012
3
0.400
Why?
Pneumopericardium
1
2012
3
0.400
Why?
Puerperal Disorders
1
2012
14
0.400
Why?
Epithelioid Cells
1
2012
4
0.400
Why?
Pericardium
1
2012
35
0.390
Why?
Xenograft Model Antitumor Assays
2
2014
181
0.390
Why?
Lung
4
2021
835
0.390
Why?
Lymphatic Metastasis
2
2011
68
0.390
Why?
Matrix Metalloproteinase 9
1
2012
59
0.390
Why?
Thoracotomy
3
2021
45
0.370
Why?
Cesarean Section
1
2012
96
0.370
Why?
Surgical Flaps
1
2012
102
0.360
Why?
Models, Animal
1
2011
221
0.360
Why?
Neoplasm Metastasis
1
2011
196
0.360
Why?
Monitoring, Intraoperative
1
2010
46
0.360
Why?
Oximetry
1
2010
47
0.350
Why?
Digestive System Surgical Procedures
1
2010
87
0.340
Why?
Adenocarcinoma
3
2022
324
0.330
Why?
Pneumothorax
2
2024
43
0.330
Why?
Esophagus
2
2023
53
0.310
Why?
Research Support as Topic
1
2009
44
0.310
Why?
Female
19
2024
30914
0.310
Why?
Health Care Reform
1
2009
88
0.310
Why?
Bronchogenic Cyst
1
2008
2
0.310
Why?
Science
1
2009
34
0.310
Why?
Mediastinal Neoplasms
1
2008
13
0.300
Why?
Pancreatic Neoplasms
2
2010
318
0.300
Why?
Carcinoid Tumor
1
2008
14
0.300
Why?
Epidermal Cyst
1
2008
10
0.300
Why?
Insurance, Health
1
2009
141
0.300
Why?
Neoplasms, Second Primary
1
2008
41
0.300
Why?
Splenic Diseases
1
2008
14
0.300
Why?
Pancreatic Diseases
1
2008
39
0.290
Why?
Choristoma
1
2008
24
0.290
Why?
Middle Aged
14
2024
16278
0.290
Why?
Aged
13
2024
13358
0.280
Why?
Cell Transformation, Neoplastic
1
2008
193
0.280
Why?
Quality Improvement
2
2022
425
0.270
Why?
Spleen
1
2008
485
0.270
Why?
Decision Making, Computer-Assisted
1
2006
12
0.260
Why?
Prognosis
6
2022
1572
0.260
Why?
Antineoplastic Agents
1
2011
645
0.260
Why?
Computer-Assisted Instruction
1
2006
76
0.250
Why?
Urinary Bladder
1
2024
33
0.240
Why?
Male
14
2024
27582
0.230
Why?
Education, Medical, Undergraduate
1
2006
149
0.230
Why?
Aorta
1
2024
106
0.230
Why?
Animals
9
2024
19654
0.220
Why?
Swine
1
2024
348
0.220
Why?
Diagnosis, Differential
4
2012
904
0.220
Why?
Consensus
1
2024
195
0.220
Why?
Curriculum
2
2024
555
0.220
Why?
Esophageal Sphincter, Lower
1
2023
20
0.220
Why?
General Surgery
1
2006
187
0.210
Why?
Time Factors
3
2024
3583
0.210
Why?
Neoplasm Invasiveness
4
2022
243
0.210
Why?
Benchmarking
2
2023
135
0.210
Why?
Breast Neoplasms
1
2011
1124
0.210
Why?
Endoscopy
1
2023
97
0.200
Why?
Bronchoscopes
1
2022
8
0.200
Why?
Endoscopy, Gastrointestinal
1
2023
117
0.200
Why?
Simplexvirus
1
2022
24
0.200
Why?
Virtual Reality
1
2022
12
0.200
Why?
Bronchoscopy
1
2022
64
0.190
Why?
Education, Medical, Graduate
1
2024
312
0.190
Why?
Adult
11
2024
15776
0.190
Why?
Learning
1
2023
171
0.190
Why?
Adenocarcinoma in Situ
1
2021
3
0.190
Why?
Carbon Monoxide
1
2021
59
0.190
Why?
Robotics
1
2022
49
0.190
Why?
Simulation Training
1
2022
59
0.180
Why?
Carcinoma, Squamous Cell
1
2022
234
0.180
Why?
Data Warehousing
1
2020
8
0.180
Why?
Medicare
1
2024
600
0.170
Why?
United States
5
2024
7530
0.170
Why?
Healthcare Disparities
1
2023
332
0.170
Why?
Diagnostic Errors
1
2020
98
0.170
Why?
Neoplasm Recurrence, Local
3
2022
301
0.160
Why?
Predictive Value of Tests
2
2020
1029
0.160
Why?
Program Evaluation
1
2020
485
0.150
Why?
Colorectal Neoplasms
2
2012
255
0.150
Why?
Reproducibility of Results
2
2020
1554
0.140
Why?
Diagnostic Imaging
2
2011
242
0.140
Why?
Internship and Residency
1
2024
734
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2012
404
0.140
Why?
Recurrence
2
2024
577
0.140
Why?
Follow-Up Studies
4
2024
2329
0.140
Why?
Immunoenzyme Techniques
2
2012
104
0.120
Why?
Mice
4
2013
10273
0.120
Why?
Gallbladder Diseases
1
2015
26
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2014
35
0.120
Why?
Patient Selection
2
2015
447
0.120
Why?
Cholecystectomy, Laparoscopic
1
2015
46
0.120
Why?
Drainage
2
2012
145
0.120
Why?
Cell Proliferation
3
2014
941
0.120
Why?
Immunotherapy, Adoptive
1
2014
85
0.110
Why?
Aged, 80 and over
5
2024
5100
0.110
Why?
Cell Movement
2
2013
423
0.110
Why?
Receptors, Antigen, T-Cell
1
2014
279
0.100
Why?
Rupture, Spontaneous
1
2012
22
0.100
Why?
Esophageal Atresia
1
2012
10
0.100
Why?
Sternotomy
1
2012
12
0.100
Why?
Laparotomy
1
2012
46
0.100
Why?
Methods
1
2011
38
0.100
Why?
Barrett Esophagus
1
2012
33
0.100
Why?
Osteopontin
1
2011
22
0.100
Why?
Cell Adhesion
1
2012
209
0.090
Why?
Oncolytic Viruses
1
2011
7
0.090
Why?
Real-Time Polymerase Chain Reaction
1
2012
192
0.090
Why?
Chest Pain
1
2012
84
0.090
Why?
Pleural Effusion, Malignant
1
2011
6
0.090
Why?
Pleurodesis
1
2011
4
0.090
Why?
Luminescent Measurements
1
2011
37
0.090
Why?
Chest Tubes
1
2011
14
0.090
Why?
Reoperation
1
2012
255
0.090
Why?
Sus scrofa
1
2010
27
0.090
Why?
Young Adult
3
2024
4326
0.090
Why?
Catheters, Indwelling
1
2011
63
0.090
Why?
Cell Hypoxia
1
2010
43
0.090
Why?
Oligonucleotide Array Sequence Analysis
1
2012
291
0.090
Why?
CD4-Positive T-Lymphocytes
1
2014
608
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
525
0.090
Why?
Blotting, Western
1
2012
594
0.090
Why?
Palliative Care
2
2011
212
0.090
Why?
Acute Disease
1
2012
658
0.090
Why?
Solitary Fibrous Tumor, Pleural
1
2010
1
0.090
Why?
Flow Cytometry
1
2012
638
0.090
Why?
Mice, Inbred BALB C
1
2012
879
0.090
Why?
Intestines
1
2010
156
0.080
Why?
Liver Neoplasms
1
2012
277
0.080
Why?
Politics
1
2009
31
0.080
Why?
Rats, Sprague-Dawley
1
2010
569
0.080
Why?
India
1
2009
157
0.080
Why?
Gene Expression Profiling
1
2012
703
0.080
Why?
Thigh
1
2008
25
0.080
Why?
Kidney
1
2010
393
0.080
Why?
Positron-Emission Tomography
1
2009
174
0.070
Why?
Genetic Therapy
1
2014
738
0.070
Why?
Biopsy, Fine-Needle
1
2008
63
0.070
Why?
Carcinoma, Basal Cell
1
2008
61
0.070
Why?
Survival Rate
2
2024
790
0.070
Why?
Rats
1
2010
1914
0.070
Why?
Length of Stay
2
2024
768
0.070
Why?
Apoptosis
1
2012
1038
0.070
Why?
RNA, Messenger
1
2012
1469
0.070
Why?
Risk Assessment
1
2012
1915
0.060
Why?
Pleura
1
2024
11
0.060
Why?
Emergency Service, Hospital
1
2012
1024
0.060
Why?
Mice, SCID
2
2014
506
0.050
Why?
Mice, Inbred NOD
2
2014
511
0.050
Why?
Suction
1
2022
30
0.050
Why?
Kaplan-Meier Estimate
2
2013
387
0.050
Why?
Neoplasm Grading
1
2021
74
0.050
Why?
Neoplasms
1
2011
1250
0.050
Why?
Cost-Benefit Analysis
1
2022
299
0.040
Why?
Longitudinal Studies
1
2024
1226
0.040
Why?
Water
1
2022
299
0.040
Why?
Cell Line, Tumor
2
2014
1374
0.040
Why?
Mitosis
1
2021
208
0.040
Why?
Computer Simulation
1
2022
457
0.040
Why?
Prospective Studies
2
2015
3102
0.030
Why?
Conversion to Open Surgery
1
2015
6
0.030
Why?
Chimerism
1
2014
10
0.030
Why?
Operative Time
1
2015
64
0.030
Why?
Cytotoxicity, Immunologic
1
2014
142
0.030
Why?
Neoplasm Transplantation
1
2013
159
0.030
Why?
Disease-Free Survival
1
2013
233
0.030
Why?
Transduction, Genetic
1
2014
233
0.030
Why?
HEK293 Cells
1
2014
575
0.030
Why?
Organoplatinum Compounds
1
2012
18
0.020
Why?
Mucins
1
2012
23
0.020
Why?
Camptothecin
1
2012
23
0.020
Why?
Lymphocyte Activation
1
2014
739
0.020
Why?
Chemotherapy, Adjuvant
1
2012
77
0.020
Why?
Single-Blind Method
1
2012
132
0.020
Why?
Hepatectomy
1
2012
59
0.020
Why?
Fibrosis
1
2012
151
0.020
Why?
Necrosis
1
2012
138
0.020
Why?
Preoperative Care
1
2012
176
0.020
Why?
Body Mass Index
1
2015
889
0.020
Why?
Gene Expression
1
2013
807
0.020
Why?
Pancreaticoduodenectomy
1
2010
56
0.020
Why?
Multivariate Analysis
1
2012
925
0.020
Why?
Cell Differentiation
1
2014
1294
0.020
Why?
Case-Control Studies
1
2012
1056
0.020
Why?
Pilot Projects
1
2012
923
0.020
Why?
Survival Analysis
1
2009
553
0.020
Why?
Disease Progression
1
2012
1048
0.020
Why?
Cohort Studies
1
2009
2443
0.010
Why?
Risk Factors
1
2012
5014
0.010
Why?
Servais's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (236)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_